- conhecimento Artigos &publicações Breast cancer and public healthcare: survey and proposals from Brazilian Society of Mastology (SBM)Assessment of the relationship between metabolic syndrome and breast cancerFirst-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III TrialMale and female disparities in breast cancer epidemiology: A comparative cross-sectional analysis of a Brazilian cohort (2017–2021)Selecting postoperative adjuvant systemic therapy for early‐stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assaysBreast and axillary marking in the neoadjuvant setting: survey results from experts of the Brazilian society of mastologyAnalyzing Neoadjuvant Chemotherapy Effects in HER2-Low Breast Cancer: Real World DataReal-world evidence of survival outcomes in breast cancer subtypes after neoadjuvant chemotherapy in a Brazilian reference centerTwo Years Post-COVID-19: An Ecologic Study Evaluating the Impact on Brazil’s Mammographic Screening ProgramAddressing Breast Cancer Disparities in Brazil- A Roadmap for Innovative Strategies « Entradas Mais Antigas Próximas Entradas »
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
Male and female disparities in breast cancer epidemiology: A comparative cross-sectional analysis of a Brazilian cohort (2017–2021)
Selecting postoperative adjuvant systemic therapy for early‐stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays
Breast and axillary marking in the neoadjuvant setting: survey results from experts of the Brazilian society of mastology
Real-world evidence of survival outcomes in breast cancer subtypes after neoadjuvant chemotherapy in a Brazilian reference center
Two Years Post-COVID-19: An Ecologic Study Evaluating the Impact on Brazil’s Mammographic Screening Program
